These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 29440875

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Comparative study of the potential of poly(2-ethyl-2-oxazoline) as carrier in the formulation of amorphous solid dispersions of poorly soluble drugs.
    Boel E, Smeets A, Vergaelen M, De la Rosa VR, Hoogenboom R, Van den Mooter G.
    Eur J Pharm Biopharm; 2019 Nov; 144():79-90. PubMed ID: 31499162
    [Abstract] [Full Text] [Related]

  • 27. Molecular mechanism of polymer-assisting supersaturation of poorly water-soluble loratadine based on experimental observations and molecular dynamic simulations.
    Zhang S, Sun M, Zhao Y, Song X, He Z, Wang J, Sun J.
    Drug Deliv Transl Res; 2017 Oct; 7(5):738-749. PubMed ID: 28677032
    [Abstract] [Full Text] [Related]

  • 28. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V, Tajber L, Corrigan OI, Healy AM.
    Mol Pharm; 2011 Apr 04; 8(2):532-42. PubMed ID: 21323367
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Amorphous-state characterization of efavirenz--polymer hot-melt extrusion systems for dissolution enhancement.
    Sathigari SK, Radhakrishnan VK, Davis VA, Parsons DL, Babu RJ.
    J Pharm Sci; 2012 Sep 04; 101(9):3456-64. PubMed ID: 22437488
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture.
    Konno H, Taylor LS.
    Pharm Res; 2008 Apr 04; 25(4):969-78. PubMed ID: 17520180
    [Abstract] [Full Text] [Related]

  • 33. Pairwise polymer blends for oral drug delivery.
    Marks JA, Wegiel LA, Taylor LS, Edgar KJ.
    J Pharm Sci; 2014 Sep 04; 103(9):2871-2883. PubMed ID: 24823790
    [Abstract] [Full Text] [Related]

  • 34. Modulation of drug release by utilizing pH-independent matrix system comprising water soluble drug verapamil hydrochloride.
    Baviskar D, Sharma R, Jain D.
    Pak J Pharm Sci; 2013 Jan 04; 26(1):137-44. PubMed ID: 23261739
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Enhancing the physical stability and supersaturation generation of amorphous drug-polyelectrolyte nanoparticle complex via incorporation of crystallization inhibitor at the nanoparticle formation step: A case of HPMC versus PVP.
    Dong B, Lim LM, Hadinoto K.
    Eur J Pharm Sci; 2019 Oct 01; 138():105035. PubMed ID: 31386892
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.